상세 보기
Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
- Jacob, Abraham;
- Ghia, Paolo;
- Pluta, Andrzej;
- Wach, Malgorzata;
- Lysak, Daniel;
- ... Lee, Jae Hoon;
- 외 14명
Citations
WEB OF SCIENCE
0- 제목
- Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
- 저자
- Jacob, Abraham; Ghia, Paolo; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kraychok, Iryna; Illes, Arpad; De La Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Avery, Eric Joseph; Lee, Jae Hoon; Wang, Denise; Patel, Priti; Quah, Cheng Seok; Jurczak, Wojciech
- 발행일
- 2021-04
- 유형
- Meeting Abstract
- 권
- 193
- 페이지
- 141 ~ 142
- 언어
- ENG
- 출판사
- WILEY
- 발행국가
- 미국
- 분량
- 2 페이지
- ISSN
- E 1365-2141
P 0007-1048